Cardiff Oncology
IPOPublic · San Diego, United States · Founded 1999 · $55.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 1999
- Business Model
- B2B
- Website
- cardiffoncology.com
- Total Funding
- $55.0M
- Last Round
- $40.0M Growth EquityDec 2024
- Rounds
- 2
- Type
- Public
About
Clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies.
Summary
Cardiff Oncology is a Biotech company based in San Diego, United States, founded in 1999. It has raised $55.0M in total across 2 rounds, most recently a $40.0M Growth Equity round in Dec 2024. Investors include Pfizer Ventures, Frazier Healthcare and CAM Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
